BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,570
+170 (1.37%)
At close: Mar 20, 2026
Market Cap400.33B -30.6%
Revenue (ttm)168.47B +29.5%
Net Income-3.23B
EPS-101.00
Shares Out31.85M
PE Ration/a
Forward PE68.76
Dividendn/a
Ex-Dividend Daten/a
Volume162,884
Average Volume336,712
Open12,530
Previous Close12,400
Day's Range12,440 - 12,930
52-Week Range12,200 - 21,250
Beta0.72
RSI40.18
Earnings DateMay 15, 2026

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 650
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

In 2025, BINEX's revenue was 168.47 billion, an increase of 29.55% compared to the previous year's 130.05 billion. Losses were -3.23 billion, -90.80% less than in 2024.

Financial Statements